ArticlePDF Available

Result of Endoscopic Third Ventriculostomy for Hydrocephalus Caused by Cerebral Aqueductal Stenosis in Infant Patients

Authors:
  • National Institute of Neurosciences and Hospital,Shere-e-bangla Nagar, Dhaka
  • Ibn Sina Hospital Dhanmondi, Dhaka, Bangladesh.

Abstract and Figures

Background Endoscopic third ventriculostomy (ETV) is one of the important management options for hydrocephalus, especially obstructive hydrocephalus. The result of ETV in different age and etiology is quite variable according to the different authors. The study was carried out to assess the success rate of ETV as a treatment for this type of hydrocephalus in infant age group. Material and Methods The study was done prospectively on infants (age ≤ 12 months) admitted in the period from January 2009 to June 2013 suffering from obstructive hydrocephalus due to cerebral aqueductal stenosis (CAS). After making the diagnosis, we counseled the patient party about the probability of high failure rate of ETV in this age group and probable necessity of a second operation. With the informed consent, we performed ETV in these cases and followed up regularly in postoperative period. Control neuroimaging studies were done whenever needed (suspected failure of ETV and suspected stomal block). Results Total 17 infants were studied. Average follow-up was 18.7 months. Twelve infants were between the age group of six and under six months while five were above six months to one year old. Fourteen (82.35%) out of 17 patients showed overall clinical improvement. Clinical improvement was seen in two (66.6%) infants aged 2 months or younger, three (75%) aged 2+ to 3 months, five (100%) aged 3+ to 6 months, and four (80%) aged 6+ months to 1 year. Two patients had bleeding during surgery. Three developed CSF leak through the burr hole. In one case (the patient's age was 2 months), the stoma was found blocked, and hydrocephalus returned 9 weeks after ETV. In two patients, in whom VP shunt was needed, “failed ETV” was obvious in early postoperative period. In this series, average ETV success score (ETVSS) was 52.35 (range: 40–70) and overall success rate was 82.35%. This indicates that ETVSS does not correlate with the outcome of ETV in infants with CAS. Conclusion Outcome of ETV for hydrocephalus from CAS in infant is quite good and ETVSS does not correlate with the outcome.
Content may be subject to copyright.
Result of Endoscopic Third Ventriculostomy for
Hydrocephalus Caused by Cerebral Aqueductal
Stenosis in Infant Patients
Forhad H. Chowdhury1Mohammod R. Haque2Khandkar A. Kawsar2Mainul H. Sarker2
Abdul Fazal Mohammod M. Haque1
1Department of Neurosurger y, National Institute of Neurosciences
and Hospital, Sher-e-bangla Nagar, Dhaka, Bangladesh
2Department of Neurosurger y, Dhaka Medical College Hospital,
Dhaka, Bangladesh
Indian J Neurosurg
Address for correspondence Forhad Hossain Chowdhur y, FCPS,
Department of Neurosurgery, National Institute of Neurosciences and
Hospital, Sher-e-bangla Nagar, Dhaka 1207, Bangladesh
(e-mail: forhadchowdhury74@yahoo.com).
Keywords
endoscopic third
ventriculostomy
obstructive
hydrocephalus
cerebral aqueductal
stenosis
ETV success score
results
Abstract Background Endoscopic third ventriculostomy (ETV) is one of the important management
options for hydrocephalus, especially obstructive hydrocephalus. The result of ETV in
different age and etiology is quite variable according to the different authors. The
study was carried out to assess the success rate of ETV as a treatment for this type of
hydrocephalus in infant age group.
Material and Methods Thestudywasdoneprospectivelyoninfants(age12
months) admitted in the period from January 2009 to June 2013 suffering from
obstructive hydrocephalus due to cerebral aqueductal stenosis (CAS). After making
the diagnosis, we counseled the patient party about the probability of high failure rate
of ETV in this age group and probable necessity of a second operation. With the
informed consent, we performed ETV in these cases and followed up regularly in
postoperative period. Control neuroimaging studies were done whenever needed
(suspected failure of ETV and suspected stomal block).
Results Total 17 infants were studied. Average follow-up was 18.7 months. Twelve
infants were between the age group of six and under six months while ve were above
six months to one year old. Fourteen (82.35%) out of 17 patients showed overall
clinical improvement. Clinical improvement was seen in two (66.6%) infants aged 2
months or younger, three (75%) aged 2
þ
to 3 months, ve (100%) aged 3
þ
to 6
months, and four (80%) aged 6
þ
months to 1 year. Two patients had bleeding during
surgery. Three developed CSF leak through the burr hole. In one case (the patients
age was 2 months), the stoma was found blocked, and hydrocephalus returned 9
weeks after ETV. In two patients, in whom VP shunt was needed, failed ETVwas
obvious in early postoperative period. In this series, average ETV success score (ETVSS)
was 52.35 (range: 4070) and overall success rate was 82.35%. This indicates that
ETVSS does not correlate with the outcome of ETV in infants with CAS.
Conclusion Outcome of ETV for hydrocephalus from CAS in infant is quite good and
ETVSS does not correlate with the outcome.
received
November 2, 2016
accepted
July 3, 2017
DOI https://doi.org/
10.1055/s-0037-1607053.
ISSN 2277-954X.
© Neurological SurgeonsSociety of
India
THIEME
Original Article
Introduction
Themostcommontherapeuticoptionsusedtotreat
hydrocephalus (HCP) include ventriculoperitoneal (VP)
drainage and neuroendoscopic surgery. Although there are
pros and cons for each option, VP shunt techniques have
high complication rate (2080%).13Endoscopic third
ventriculostomy (ETV) is well accepted for obstructive
hydrocephalus of various etiologies.410 It is considered as
a better alternative to shunt surgery in obstructive HCP.
Though some authors advocate ETV in patients of all
ages,13,11 others showed that patients younger than
1 year have a higher failure rate for ETVs compared with
older children.12 Therefore, we present our experience of
ETV in obstructive HCP caused by congenital cerebral
aqueductal stenosis (CAS), comparing between the
patients below six months and above.
Material and Methods
The presentstudy was done prospectively in the Neurosurgery
Department, Dhaka Medical College Hospital, Islami Bank
Central Hospital, and Ibn Sina Hospital, Dhaka, Bangladesh,
on infants (age 12 months) with obstructive HCP due
to CAS, admitted in the period from January 2009 to
June 2013. Failed VP shunts in CAS cases were also included.
CAS patients associated with arachnoid cyst, meningocele, or
myelomeningocele were excluded (to make the study
homogeneous) where CAS caused triventriculomegaly. The
patients whowere not available for at least 6-month follow-up
were not included in the study. (Regular follow-up in a
developing country such as Bangladesh is a challenging job.
Availability of mobile and video phone calls helped in regular
follow-ups in these cases. Sometimes we had to pay some
money to the parents for meeting up their traveling cost.)
For diagnosis of HCP, ultrasonogram (USG), computed
tomography (CT) scan, and magnetic resonance imaging
(MRI) of the brain were used. USG of the brain was done in
eight cases as a screening test by the attending physician.
CT scan of the brain was done in 15 cases and MRI was
done only in 2 cases because the parents were unwilling to
let the infants undergo general anesthesia. After making
the diagnosis, we counseled the patientsparentsyabout
the probability of high failure rate of ETV in this age group
and probable necessity of a second operation. With the
informed consent, we performed ETV in these cases. The
study was carried out to assess the success rate of ETV as a
treatment for this type of HCP in such age group. Patients were
followed up postoperatively from days 1 through 7; then
weekly assessment for 2 months, and then monthly
assessment for 12 months followed by 3 monthly
assessment of the head circumference, anterior fontanelle,
cerebrospinal uid (CSF) leak, wound infection, fever, or
any other complaints. ETV was considered as successful
if the patient improved clinically. Control neuroimaging
studies were done whenever needed (suspected failure
of ETV and suspected stomal block) or after 6 months to
1 year.
Operative Technical Points
The operative technique of ETV is standardized and is not
mentioned here. After making an opening in the third
ventricular oor, endoscope was advanced below through
the opening to inspect further. If an imperforate membrane of
Liliequist was identied, lying beneath the oor of the third
ventricle was opened under direct endoscopic visualization.
If any hemorrhage was encountered during the procedure,
copious warm uid irrigation was used until all bleeding was
visibly stopped and the ventricular CSF was clear. We used
careful intermittent closure of outow channel to create
tamponade effect. In one patient, in whom irrigation failed to
clear vision, blood-stained CSF and normal saline were
aspirated by a Fogarty catheter whose tip was cut off before
aspiration. After removal of endoscope with sheath, wound
was closed accordingly. First dural closer was done, and then
bone dust and spongostan were placed at the burr hole.
Pericranial-aponeurotic layer was closed carefully. Finally skin
was closed with interrupted stitches.
Results
Total 17 infants were studied, out of these 8 (47%) were male
and 9 (53%) female. Follow-up range was 7 to 37 months
(average: 18.7 months). Details of all patients are shown in
Tables 1 and 2. There were seven (41%) infants aged 3
months or younger and three (17.6%) were 2 months old or
younger. Twelve (70.6%) were 6 months or younger whereas
ve (29.4%) were older than 6 months to 1 year. No one was
born prematurely. There was history of febrile illness in the
mother during pregnancy among three infants. Ten (58.8%)
infants were the rst issue of the parent. One patient had
history of mild birth asphyxia. Two infants had completely
healthy twin siblings. Mild to moderate underweight was
present in six (35%) cases. Gross protein energy malnutrition
(marasmus) was present in one case for which concurrent
nutritional therapy had to given during the perioperative
period of ETV. Low-birth weight (LBW) was present in three
(17.6%) cases. Three, four, ve, and ve infants were aged 2
months or younger, 02
þ
to 03 months, 03
þ
to 06 months,
and 06
þ
months to 1 year, respectively. There was no history
or event of pre-ETV intraventricular hemorrhage or
infection (even in failed VP shunt cases). Fourteen (82.35%)
out of 17 patients showed overall clinical improvement
(Figs. 13). Clinical improvement was seen in two (66.6%)
infants aged 2 months or younger, three (75%) aged 2
þ
to 3
months, ve (100%) aged 3
þ
to 6 months, and four (80%)
aged 6
þ
months to 1 year. Out of three LBW infants (all
aged <2 months), one (33.3%) patient failed ETV. Average
age of this series was 5.5 months. The mean age of the
patients with success was 5.6 months. Average ETV success
score (ETVSS) of the series was 52.35. Average ETVSS was
47.5 (range: 4050) and 64 (6070) in infants aged 6 months
or younger and 06
þ
to 12 months age group, respectively.
Two patients had bleeding during surgery. In one case,
continuous irrigation along with endoscopic tip pressure
and pressure by inated Fogarty balloon were needed to
Indian Journal of Neurosurgery
ETV for Cerebral Aqueductal Stenosis in Infant Chowdhury et al.
stop bleeding. Force aspiration through sheath channel and
cut tip Fogarty catheterneeded to make vision clear in
other case. No procedure had to be abandoned. Three
patients developed CSF leak through the burr hole. Leak
stopped spontaneously in 3 days in one patient. One patient
needed three times lumbar puncture whereas in the
remaining patients (there was perioperative hemorrhage),
repeated lumbar puncture and re-ETV failed to resolve the
problem and nally VP shunt was needed. In one patient
(age 2 months), the stoma was found blocked and HCP
returned 9 weeks after ETV. As re-ETV failed in this case, the
authors went for VP shunt that resolved the problem. In
another case in which ETV failed (ETV was done at the age of
9 months for complication of previously done VP shunt), we
had to return to VP shunt. Where VP shunt was needed,
failed ETVwas obvious in early postoperative period cases
in two cases, and in the remaining cases, features of HCP
reappeared 9 weeks after ETV due to stomal block. The
patientsages were was 2, 4, and 9 months at the time of ETV
when VP shunts were needed. We faced no mortality,
diabetes insipidus (DI), or endocrine abnormalities.
Transient postoperative fever was found in three cases.
ETV was done in ve cases in which previously done VP
shunt was failed; four out of ve responded well with ETV
and one needed repeat VP shunt.
Discussion
New interest developed in the use of ETV for the treatment
of obstructive HCP along with advanced beroptic and lens
technology. In recent time, the better success of third
ventriculostomy could be attributed to better patient
selection and improvements in endoscope, better imaging,
advanced surgical technique, and instruments. ETV is
considered treatment of choice in obstructive HCP. It is
also now used in some communicating HCP, such as normal
pressure HCP by some authors. Although ETV can be used in
selected patients of all types of HCP, the success of ETV in
obstructive HCP is better than that in communicating HCP.4
Obstructive HCP occurs commonly due to congenital CAS,
posterior third ventricle tumor, cerebellopontine angle tumor,
and other posterior fossa tumor of obstructive variety. HCPs
following cerebellar infarct, Dandy-Walker malformation,
syringomyelia with or without Chiarismalformation,shunt
malfunction, encephalocele, craniosynostosis, and intraventricular
hematoma are usually of obstructive type. Myelomeningocele
withHCP,slitventriclesyndrome,andmultiloculatedHCPsare
also of obstructive type. HCP secondary to intraventricular
hemorrhage, ventriculitis, meningitis, and postoperative cases
after complete excision of mass lesions are of communicating
variety. Normal pressure HCP is of communicating type. When
Table 1 Detailsofpatients:06monthsofage
Age (mo),
sex and,
figure
Diag-
nosis/
ETVSS
Pre-ETV
VP shunt
H/O birth
asphyxia,
premature
delivery,
LBW, PEM
Perioperative
complication
Postoperative
complication
F/U
(mo)
ETV failed/
Stoma
block
Reoperation
4/F
(Fig. 1)
CAS/50 –– – 14 ––
4/F CAS/50 Bleeding CSF leakLP
failed
32 Failed ETV Re-ETV
failed: VP
shunt done
3/F CAS/50 –– – 27 ––
23 d/F CAS/40 LBW ––15 ––
2/F CAS/50 –– – 10 ––
5/M CAS/50 –– – 7––
5/M CAS/40 Failed VP
shunt
–– – 23 ––
3/F
(Fig. 2)
CAS/50 –– Bleeding CSF leak-
healed by LP
37 ––
3/F CAS/50 –– – Fever 09 ––
3/M
(Fig. 3)
CAS/50 –– – 11 ––
5/F CAS/40 Failed VP
shunt
–– – 12 ––
2/M CAS/50 LBW ––21 Stoma
blocked-
9wkafter
ETV
Re-ETV
failed: VP
shunt done
Abbreviations: CAS, cerebral aqueductal stenosis; CSF, cerebrospinal uid; ETV, endoscopic third ventriculostomy; ETVSS, ETV success score; F/U,
follow-up; F, female; LBW, low-birth weight; LP, lumbar puncture; M, male; PEM, protein energy malnutrition; VP, ventriculoperitoneal.
Indian Journal of Neurosurgery
ETV for Cerebral Aqueductal Stenosis in Infant Chowdhury et al.
boththeelementofobstructionandthedefectintheCSF
absorption persist, it is complex HCP.4,13
CAS is a common cause of obstructive (noncommunicating)
HCP. It could be due to congenital stenosis, acquired idiopathic,
postinfectious or posthemorrhagic, and stenosis secondary to
tumor. In congenital stenosis, aqueduct could be narrow or
completely obstructed. Complete or near-complete obstruction
usually presents in an early age, whereas if obstruction is
partial, patients may be asymptomatic or present at an later
age. ETV instead of a shunt placement is considered a better
option for noncommunicating HCP secondary to congenital
aqueductal stenosis. Results of ETV are better in congenital HCP
Table 2 Detailsofpatients:6
þ
12 months of age
Age (mo)
and sex
Diag-
nosis/
ETVSS
Pre-ETV
VP shunt
H/O birth
asphyxia,
premature
delivery,
LBW, PEM
Perioperative
complication
Postoperative
complication
F/U
(mo)
Stoma block Reoperation
9/M CAS/60 VP shunt
block with
downward
migration
PEM
(marasmus)
–– 35 ––
12/M CAS/70 –– – CSF leak:
stopped
spontaneously
21 ––
9/M CAS/60 CSF leak at
abdominal
end of VP
shunt (at
the age of
3mo)
Mild birth
asphyxia
None None 15 ETV failed
(failed to
improve
symptoms)
Re-VP shunt
on the
opposite
side
12/F CAS/70 –– – 36 ––
9/M CAS/60 VP shunt:
at the age
of 2 mo
–– Fever 13 ––
Abbreviations: CAS, cerebral aqueductal stenosis; CSF, cerebrospinal uid; ETV, endoscopic third ventriculostomy; ETVSS, ETV success score; F,
female; F/U, follow-up; M, male; mo, month; PEM, protein energy malnutrition; VP, ventriculoperitoneal.
Fig. 1 Upper rowpreoperative serial axial CT scan of brain showing triventriculomegaly at the age of 4 months. Lower rowpostoperative
serial axial CT scan of brain at the age of 2 years. CT, computed tomography.
Indian Journal of Neurosurgery
ETV for Cerebral Aqueductal Stenosis in Infant Chowdhury et al.
due to aqueductal stenosis as compared with posthemorrhagic
or postinfective HCP.4,5 Perioperative neural injury, such as
thalamic, forniceal, hypothalamic, and midbrain, are not
uncommon. Intraoperative bradycardia and hemorrhages
including fatal hemorrhage due to basilar artery rupture are
also reported. Attempts to perforate the ventricular oor can
lead to bleeding, especially in HCP following an infection
and hemorrhage. From our experience, all can be easily avoided
by appropriate placing of burr hole and careful surgical
manipulation of endoinstruments and neurostructures.
Signicant side movement should be avoided to prevent
bleeding due to an injury to structures, such as the fornix and
veins at foramen of Monro. We did not face any neural damage
except controllable bleeding per operatively. Rarely, blood
might trickle from burr-hole site into the ventricle; proper
hemostasis must be achieved before entering the ventricle.4
Perioperative bleeding is seen in about 3 to 8%3,14 of cases.
Aspiration of clots and thorough irrigation of ventricular cavity
should be done after bleeding stops; these measures can reduce
chances of stoma closure.3Bradycardia may occur from raised
ICP due to inappropriate irrigation and brainstem stretching.4
Central nervous system infections, fever, stoma block, CSF
leak, and postoperative intracranial hematomas were also seen.
Postoperative mortality is also reported.15,16 DI, hemiparesis,
gaze palsy, memory disorders, altered consciousness, weight
Fig. 2 (A) Preoperative picture of patient with hydrocephalus. (B)
Preoperative MRI sagittal section in T1W image showing
triventriculomegaly with CAS. (C) Early postoperative picture of
patient after ETV. (D) Late postoperative picture of patient with
successful ETV. CAS, cerebral aqueductal stenosis; ETV, endoscopic
third ventriculostomy.
Fig. 3 (A) Preoperative picture of patient with hydrocephalus. (B) Pre-E TVC Tscan axial sections show ing triventriculomegaly due to CAS. (C, D)
Early postoperative pictures of patient with successful ETV. CAS, cerebral aqueductal stenosis; CT, computed tomography; ETV, endoscopic
third ventriculostomy.
Indian Journal of Neurosurgery
ETV for Cerebral Aqueductal Stenosis in Infant Chowdhury et al.
gain, precocious puberty, and abnormal prolactin levels can
occur after ETV. However, abnormal prolactin levels are not
clinical signicant.17 DI was reported by Choi et al18 in 3%
cases. Chronic subdural hematoma or subdural hygroma can
occur after ETV. Rare complications such as postoperative
hyperkalemia, severe parkinsonism, acute respiratory alkalosis,
and tachypnea can occur after ETV. Overall complication rate
after ETV is about 2 to 15%, but the permanent complications are
few.4,1921
Postoperative fever could occur due to use of electrocautery,
which should be avoided. We faced postoperative fever in three
cases that subsided spontaneously. Postoperative CSF leak could
be avoided by plugging cortical and dural opening by Gelfoam,
direct dural closure, especially in large ventriculomegaly in
infants, or by using articial dural substitute and tissue sealant
in at-risk patients. Postoperative CSF leak can also be reduced
by galeal-pericranial ap.4,22 Incidence of CSF leak after ETV
have varied between 2 and 7%. In the series of Yadav et al, CSF
leak occurred in 16% patients in whom half of the cases of CSF
leak stopped spontaneously. The causes of persistent leak
includeclosureofstoma,failureofclosureofthedura,thinned-
out scalp, and thin cortical mantle in patients with gross HCP.
Dura closer should be done properly, especially in patients with
gross HCP with thin cortical mantle.3Postoperative
complications in the ETV patients usually occur within
1 month after operation. However, delayed complications
including stoma block can occur. Delayed stoma block, though
very rare, can be fatal.23 Intraoperative observation of thickened
arachnoid membranes at the level of the interpeduncular
cisterns at the time of ETV should be considered a signicant
risk of stoma block.24 Postoperative failures usually occur early;
regular clinical and radiologic follow-up must be performed,
especially in the rst years after the ETV.25 According to
Mohanty et al,26 reclosure of the stoma because of gliosis and
scarring has been observed in 6 to 15% of ETV failures. The high
rateofreclosureininfantscanbeexplainedasfollows:asCSF
absorption is impeded, there is a greater tendency for the
development of new arachnoid membranes in infants, and
there is also growth of gliotic, ependymal, and scar tissue.12 ICP
monitoring with or without external ventricular drainage
during the immediate postoperative period after ETV could be
required in patients who continue to have clinical features of
raised ICP or failed to show an improvement after ETV. Few
patients fail to show an improvement despite patent stoma
after ETV. CSF drainage by lumbar puncture helps by increasing
thecomplianceandthebufferingcapacitiesofthespinal
subarachnoid spaces. It probably decreases the CSF outow
resistance from the ventricular system, facilitates the decrease
in the ventricular volume, and allows faster permeation of CSF
in the intracranial subarachnoid spaces. A cycle of one to three
lumbar punctures should always be performed in patients who
remain symptomatic after ETV, before ETV is assumed to have
failed.4,2729
A reduction in the ventricular size detected soon after
ETV is associated with a good clinical outcome. This decrease
in ventricular size continues during the rst few months
after surgery. Reduction in the size of third ventricle width is
more than that in lateral ventricle size width after successful
ETV. Magnetic resonance ventriculography was effective in
assessing subarachnoid space and stoma patency after ETV.
T2-weighted turbo inversion-recovery magnetic resonance
images can detect ow-void sign better. Cine phase-contrast
(PC) MRI is useful even if no ow void is seen. Cine PC MRI
may be used to determine the patency of the stoma and may
be used in follow-up.4,24,30,31
Determining the best candidates for ETV has been difcult,
with conicting reports on who are the best candidates,
particularly regarding the effect of age and etiology. Reports
have indicated that outcome is a function of age23,32,33
independent of age,1,34 a function of etiology,1,3537 or a
function of both age and etiology.38 More recent evidence
from larger, and in one case, multicenter series has supported
the nding that age is the main determinant of outcome with
younger children, particularly neonates, faring worse.39,40 The
other standard technique of CSF diversion, a CSF shunt, has
rarely been compared with ETV, with results suggesting no
difference41 or a slight advantage in terms of cost-
effectiveness for ETV.42 CSF shunt outcomes are also known
to be inuenced by age, with younger children also faring
more poorly.4345
There are controversies regarding the success of ETV in
infants. Some authors reported poor results, especially in
neonates and in infants younger than 2 months.4Shim et
al46 suggested that simultaneous ETV and VP shunt should
be performed in infantile HCP due to poor results of ETV
alone. The higher clinical success rate of ETV in the series by
Yadav et al was 83.7%.3Success rates of 71%,47 64%,48 and
85%49 were observed in other studies done in infants
whereas the success rates varied from 7614 to 91.5% in
other age group patients.18 They found that failure rate of
ETV in LBW premature infants was higher (60%) as
compared to full-term normal-birth-weight infants
(12.3%).3In the case of children under 1 year, long-term
shunt independence was 75% in the series by Stan et al.50
The success of these patients was inuenced much by the
technique used. In the absence of plexus coagulation, the
success rate of the operation is signicantly reduced. The
study by Warf et al proved the difference in the success rate
with 48.6% in patients in whom they practiced only ETV
compared to 81.9% in those in whom they practiced ETV and
plexus coagulation both.51 Kulkarni et al52 reported the
relative higher risk of initial failure in ETV than shunt in
children. The relative risk becomes progressively lower for
ETV after about 3 months. Patients could experience a long-
term treatment survival advantage after an early high-risk
period of ETV failure as compared to shunt. They observed
that it might take several years, however, to realize this
benet. There have been several studies of the effectiveness
of ETV in children under two years of age. Kadrian et al
reported a strong effect of the patients age on outcome.40
The authors reported the percentages of patients presumed
to have a functioning ETV after 5 yearsas follows: 41% in
patients 1- to 6-month old at the time of surgery, 58% in
patients 6- to 24-month old, and more than 70% in patients
older than 24 months. These results correspond to the data
reported by other authors.32 However, Javadpour et al47
Indian Journal of Neurosurgery
ETV for Cerebral Aqueductal Stenosis in Infant Chowdhury et al.
reported ETV success rate of 33% (continued patency during
follow-up in 7 of 21 patients) and found that success
depended on etiology rather than on patient age. Baldauf
et al38 reported 50% success rate in idiopathic aqueductal
stenosis. Analysis of the success and failure of ETV in infants
in the Netherlands conrmed that ETV should be considered
as an initial treatment that carries a low risk of morbidity in
these infants. As the immune system rapidly matures,
postponing shunt implantation for several months or even
weeks would make ETV worthwhile. Moreover, the authors
noted that a second ETV should always be considered before
shunt placement in young patients with a failed ETV, as the
probability of ETV success rapidly increases 4 months after
birth.53 The largest study of ETV success in very young
children was conducted in Uganda and it involved 153
children younger than 1 year.54 The ETV success rate among
these patients was 53%. The surgery success rates for
patients with aqueductal obstruction were 70%. Fritsch et
al,1reporting a 39% ETV success rate, presented ETV as an
effective alternative for the treatment of obstructive HCP in
infants younger than 1 year. Korean authors have reported
simultaneous implantatio n of a VP shunt and ETV as the rst
choice of treatment for hydrocephalic patients younger than
1 year (83.9% success rate). Perhaps placement of the
ventricular catheter in the prepontine cistern under
endoscopic guidance reduces the risk of stoma closure and
development of new arachnoid membranes.55 On the other
hand, these combined procedures do not provide patients
with shunt independence and or freedom from shunt
complications.12 In the small series of ETV under the age
of 6 months in obstructive HCP due to CAS, Zodi et al found
very low success rate (only 12.5% cases were successful).12
Success rates of ETV in different series are shown in
(Table 3).1,11,12,25,39,41,48,51,5660 ETVSS is used to predict
the outcome of ETV before operation.52 In this series,
average ETVSS was 52.35 (range: 4070) and overall
success rate was 82.35%. This indicates that ETVSS does not
correlate with the outcome of ETV in infants with CAS. In our
series, we did not nd any impact of age on the success of
ETV in CAS. In this small series, success rate of ETV in CAS
under the age of 1 year was not low (82.35%) without
choroid plexus coagulation. It is not well understood; result
of success in ETV in obstructive HCP in infant was so variable
in different series. During operation the authors frequently
noticed extra-arachnoidal membrane after fenestration of
third ventricular oor; the authors went for fenestration of
that membrane(s) almost routinely to the anterior surface of
the basilar artery. In future, larger series with more number
of cases will probably answer the question preciously.
Conclusion
Outcome of ETV for HCP from CAS in infant is quite good
with low risk of complication even in very young infant, and
ETVSS does not correlate with the outcome.
References
1Fritsch MJ, Kienke S, Ankermann T, Padoin M, Mehdorn HM.
Endoscopic third ventriculostomy in infants. J Neurosurg 2005;
103(1, Suppl):5053
2Pereira J, Lamas R, Ayres-Basto M, Seixas ML, Vaz R. [Neuroendoscopy
in the treatment of obstructive hydrocephaly] [in Portuguese]. Acta
Med Port 2002;15(05):355364
3Yadav YR, Jaiswal S, Adam N, Basoor A, Jain G. Endoscopic third
ventriculostomy in infants. Neurol India 2006;54(02):161163
4Yadav YR, Parihar V, Pande S, Namdev H, Agarwal M. Endoscopic
third ventriculostomy. J Neurosci Rural Pract 2012;3(02):163173
5van Beijnum J, Hanlo PW, Fischer K, et al. Laser-assisted
endoscopic third ventriculostomy: long-term results in a series
Table 3 Comparative success rate of ETV in aqueductal obstruction by some published series
Series No. of patients Age group Result of success
rate (%)
Fritsch et al (2005)13 Pediatric (<1 y) 100
Cinalli et al (1999)11 119 Pediatric 72
Zohdi et al (2013)12 08 Pediatric 12.5
Gangemi et al (2007)25 88 Pediatric plus adult 87
Drake (2007)39 107 Pediatric 65 and 52 success rates at 1 and
5 y, respectively
Tuli et al (1999)41 32 Pediatric 56
Gorayeb et al (2004)48 11 Pediatric (<1y) 55
Warf et al (2005)51 153 Pediatric 53 in all patients and 70 in
aqueductal obstruction
Fukuhara et al (2000)57 37 Pediatric plus adult 68
Bognar et al (2005)58 76 Pediatric plus adult 71
Koch-Wiewrodt and Wagner (2006)59 13 Pediatric (<1y) 54
Sacko et al (2010)60 350 Pediatric plus adult 61
Abbreviation: ETV, endoscopic third ventriculostomy; y, year.
Indian Journal of Neurosurgery
ETV for Cerebral Aqueductal Stenosis in Infant Chowdhury et al.
of 202 patients. Neurosurger y 2008;62(02):437443, discussion
443444
6Mohanty A, Santosh V, Devi BI, Satish S, Biswas A. Efcacy of
simultaneous single-trajectory endoscopic tumor biopsy and
endoscopic cerebrospinal uid diversion pr ocedures in intra- and
paraventricular tumors. Neurosurg Focus 2011;30(04):E4
7Morgenstern PF, Osbun N, Schwartz TH, Greeneld JP, Tsiouris AJ,
Souweidane MM. Pineal region tumors: an optimal approach for
simultaneous endoscopic third ventriculostomy and biopsy.
Neurosurg Focus 2011;30(04):E3
8Al-Tamimi YZ, Bhargava D, Surash S, et al. Endoscopic biopsy during
third ventriculostomy in paediatric pineal region tumours. Childs
Nerv Syst 2008;24(11):13231326
9Oppido PA, Fiorindi A, Benvenuti L, et al. Neuroendoscopic biopsy
of ventricular tumors: a multicentric experience. Neurosurg Focus
2011;30(04):E2
10 Roopesh Kumar SV, Mohanty A, Santosh V, et al. Endoscopic
options in management of posterior third ventricular tumors.
Childs Nerv Syst 2007;23(10):11351145
11 Cinalli G, Sainte-Rose C, Chumas P, et al. Failure of third
ventriculostomy in the treatment of aqueductal stenosis in
children. J Neurosurg 1999;90(03):448454
12 Zohdi AZ, El Damaty AM, Aly KB, El Refaee EA. Success rate of
endoscopic third ventriculostomy in infants below six months of
age with congenital obstructive hydrocephalus (a preliminary
study of eight cases). Asian J Neurosurg 2013;8(03):147152
13 Yadav YR, Mukerji G, Parihar V, Sinha M, Pandey S. Complex
hydrocephalus (combination of communicating and obstructive
type): an important cause of failed endoscopic third
ventriculostomy. BMC Res Notes 2009;2:137
14 Hopf NJ, Grunert P, Fries G, Resch KD, Perneczky A. Endoscopic third
ventriculostomy: outcome analysis of 100 consecutive procedures.
Neurosurgery 1999;44(04):795804, discussion 804806
15 Erşahin Y, Arslan D. Complications of endoscopic third
ventriculostomy. Childs Nerv Syst 2008;24(08):943948
16 Bouras T, Sgouros S. Complications of endoscopic third
ventriculostomy. J Neurosurg Pediatr 2011;7(06):643649
17 Fritsch MJ, Bauer M, Partsch CJ, Sippell WG, Mehdorn HM.
Endocrine evaluation after endoscopic third ventriculostomy
(ETV) in children. Childs Ner v Syst 2007;23(06):627631
18 Choi JU, Kim DS, Kim SH. Endoscopic surgery for obstructive
hydrocephalus. Yonsei Med J 1999;40(06):600607
19 Bernard R, Vallee F, Mateo J, et al. Uncontrollable high-frequency
tachypnea: a rare and nearly fatal complication of endoscopic
third ventriculostomy: case report and literature review. Minim
Invasive Neurosurg 2010;53(56):270272
20 Akiyama T, Tanizaki Y, Akaji K, et al. Severe parkinsonism following
endoscopic third ventriculostomy for non-communicating
hydrocephaluscase report. Neurol Med Chir (Tokyo) 2011;
51(01):6063
21 Sung HJ, Sohn JT, Kim JG, et al. Acute respiratory alkalosis
occurring after endoscopic third ventriculostomyacase
report. Korean J Anesthesiol 2010;59(Suppl):S194S196
22 Mohanty A, Suman R. Role of galeal-pericranial ap in reducing
postoperative CSF leak in patients with intracranial endoscopic
procedures. Childs Nerv Syst 2008;24(08):961964
23 Lipina R, Palecek T, Reguli S, Kovarova M. Death in consequence of
late failure of endoscopic third ventriculostomy. Childs Nerv Syst
2007;23(07):815819
24 Faggin R, Calderone M, Denaro L, Meneghini L, dAvella D. Long-
term operative failure of endoscopic third ventriculostomy in
pediatric patients: the role of cine phase-contrast MR imaging.
Neurosurg Focus 2011;30(04):E1
25 Gangemi M, Mascari C, Maiuri F, Godano U, Donati P, Longatti PL.
Long-term outcome of endoscopic third ventriculostomy in
obstructive hydrocephalus. Minim Invasive Neurosurg 2007;
50(05):265269
26 Mohanty A, Vasudev MK, Sampath S, Radhesh S, Sastry
Kolluri VR. Failed endoscopic third ventriculostomy in children:
management options. Pediatr Neurosurg 2002;37(06):304309
27 Elgamal EA. Continuous monitoring of intracranial pressure after
endoscopic third ventriculostomy in the management of CSF
shunt failure. Minim Invasive Neurosurg 2010;53(02):4954
28 Lee SH, Kong DS, Seol HJ, Shin HJ. Endoscopic third
ventriculostomy in patients with shunt malfunction. J Korean
Neurosurg Soc 2011;49(04):217221
29 Yadav YR, Parihar V, Sinha M. Lumbar peritoneal shunt. Neurol
India 2010;58(02):179184
30 Santamarta D, Martin-Vallejo J, Díaz-Alvarez A, Maillo A. Changes
in ventricular size after endoscopic third ventriculostomy. Acta
Neurochir (Wien) 2008;150(02):119127, discussion 127
31 Singh I, Haris M, Husain M, Husain N, Rastogi M, Gupta RK. Role of
endoscopic third ventriculostomy in patients with communicating
hydrocephalus: an evaluation by MR ventriculography. Neurosurg
Rev 2008;31(03):319325
32 Koch D, Wagner W. Endoscopic third ventriculostomy in infants
of less than 1 year of age: which factors inuence the outcome?
Childs Nerv Syst 2004;20(06):405411
33 Wagner W, Koch D. Mechanisms of failure after endoscopic third
ventriculostomy in young infants. J Neurosurg 2005;103(1, Suppl):
4349
34 OBrien DF, Seghedoni A, Collins DR, Hayhurst C, Mallucci CL. Is
there an indication for ETV in young infants in aetiologies other
than isolated aqueduct stenosis? Childs Nerv Syst 2006;22(12):
15651572
35 Beems T, Grotenhuis JA. Is the success rate of endoscopic third
ventriculostomy age-dependent? An analysis of the results of
endoscopic third ventriculostomy in young children. Childs Nerv
Syst 2002;18(11):605608
36 Etus V, Ceylan S. Success of endoscopic third ventriculostomy in
children less than 2 years of age. Neurosurg Rev 2005;28(04):
284288
37 Feng H, Huang G, Liao X, et al. Endoscopic third ventriculostomy
in the management of obstructive hydrocephalus: an outcome
analysis. J Neurosurg 2004;100(04):626633
38 Baldauf J, Oertel J, Gaab MR, Schroeder HW. Endoscopic third
ventriculostomy in children younger than 2 years of age. Childs
Nerv Syst 2007;23(06):623626
39 Drake JM; Canadian Pediatric Neurosurgery Study Group.
Endoscopic third ventriculostomy in pediatric patients: the
Canadian experience. Neurosurgery 2007;60(05):881886,
discussion 881886
40 Kadrian D, van Gelder J, Florida D, et al. Long-term reliability of
endoscopic third ventriculostomy. Neurosurgery 2005;56(06):
12711278, discussion 1278
41 Tuli S, Alshail E, Drake J. Third ventriculostomy versus
cerebrospinal uid shunt as a rst procedure in pediatric
hydrocephalus. Pediatr Neurosurg 1999;30(01):1115
42 Garton HJ, Kestle JR, Cochrane DD, Steinbok P. A cost-
effectiveness analysis of endoscopic third ventriculostomy.
Neurosurgery 2002;51(01):6977, discussion 7778
43 Tuli S, Drake J, Lawless J, Wigg M, Lamber ti-Pasculli M. Risk
factors for repeated cerebrospinal shunt failures in pediatric
patients with hydrocephalus. J Neurosurg 2000;92(01):3138
44 Tuli S, OHayon B, Drake J, Clarke M, Kestle J. Change in ventricular
size and effect of ventricular catheter placement in pediatric
patients with shunted hydrocephalus. Neurosurgery 1999;
45(06):13291333, discussion 13331335
45 Drake JM, Kulkarni AV, Kestle J. Endos copic third ventriculostomy
versus ventriculoperitoneal shunt in pediatric patients: a
decision analysis. Childs Nerv Syst 2009;25(04):467472
46 Shim KW, Kim DS, Choi JU. Simultaneous endoscopic third
ventriculostomy and ventriculoperitoneal shunt for infantile
hydrocephalus. Childs Nerv Syst 2008;24(04):443451
Indian Journal of Neurosurgery
ETV for Cerebral Aqueductal Stenosis in Infant Chowdhury et al.
47 Javadpour M, Mallucci C, Brodbelt A, Golash A, May P. The impact
of endoscopic third ventriculostomy on the management of
newly diagnosed hydrocephalus in infants. Pediatr Neurosurg
2001;35(03):131135
48 Gorayeb RP, Cavalheiro S, Zymberg ST. Endoscopic third
ventriculostomy in children younger than 1 year of age.
J Neurosurg 2004;100(5, Suppl Pediatrics):427429
49 Buxton N, Macarthur D, Mallucci C, Punt J, Vloeberghs M.
Neuroendoscopic third ventriculostomy in patients less than 1
year old. Pediatr Neurosurg 1998;29(02):7376
50 Stan H, Kiss PA, Stan A, Florian IS. Neuroendoscopic surgery
in hydrocephalus. Romanian Neurosurger 2012;19(04):
264271
51 Warf BC, Tracy S, Mugamba J. Long-term outcome for endoscopic
third ventriculostomy alone or in combination with choroid
plexus cauterization for congenital aqueduc tal stenosis in African
infants. J Neurosurg Pediatr 2012;10(02):108111
52 Kulkarni AV, Drake JM, Kestle JR, Mallucci CL, Sgouros S,
Constantini S; Canadian Pediatric Neurosurgery Study Group.
Endoscopic third ventriculostomy vs cerebrospinal uid shunt in
the treatment of hydrocephalus in children: a propensity score-
adjusted analysis. Neurosurgery 2010;67(03):588593
53 Balthasar AJ, Kort H, Cornips EM, Beuls EA, Weber JW, Vles JS.
Analysis of the success and failure of endoscopic third
ventriculostomy in infants less than 1 year of age. Childs Nerv
Syst 2007;23(02):151155
54 Warf BC. Hydrocephalus in Uganda: the predominance of
infectious origin and primary management with endoscopic
third ventriculostomy. J Neurosurg 2005;102(1, Suppl):115
55 Stan H, Popa C, Iosif A, Nistor S. Combined endoscopically guided
third ventriculostomy with prepontine cistern placement of the
ventricular catheter in a ventriculo-peritoneal shunt: technical
note. Minim Invasive Neurosurg 2007;50(04):247250
56 Spennato P, Tazi S, Bekaert O, Cinalli G, Decq P. Endoscopic third
ventriculostomy for idiopathic aqueductal stenosis. World
Neurosurg 2013;79(2, Suppl):21.e1321.e20
57 Fukuhara T, Vorster SJ, Luciano MG. Risk factors for failure of
endoscopic third ventriculostomy for obstructive hydrocephalus.
Neurosurgery 2000;46(05):11001111
58 Bognar L, Markia B, Novak L. Retrospective analysis of 400
neuroendoscopic interventions: the Hungarian experience.
Neurosurg Focus 2005;19:E10
59 Koch-Wiewrodt D, Wagner W. Success and failure of endoscopic
third ventriculostomy in young infants: Are there different age
distributions? Childs Nerv Syst 2006;22(12):15371541
60 Sacko O, Boetto S, Lauwers-Cances V, Dupuy M, Roux FE.
Endoscopic third ventriculostomy: outcome analysis in 368
procedures. J Neurosurg Pediatr 2010;5:6874
Indian Journal of Neurosurgery
ETV for Cerebral Aqueductal Stenosis in Infant Chowdhury et al.
... ETV is well-known to be appropriate for treating obstructive hydrocephalus with various etiologies. [30] The effectiveness of ETV is still the topic of current active research, and indications for doing ETV compared to shunting operations are continuously evolving in recent years. [7]. ...
... They reported that the ETVSS did not show adequate discrimination but demonstrated excellent calibration in this population of patients 2 years and older. Chowdhury et al. [23] assessed the success rate of ETV prospectively in infant age group. Fourteen out of 17 patients (82.35%) showed overall clinical improvement. ...
Article
Full-text available
PurposeAge and etiology play a crucial role in success of endoscopic third ventriculostomy (ETV) as a treatment of obstructive hydrocephalus. Outcome is worse in infants, and controversies still exist whether ETV is superior to shunt placement. We retrospectively analyzed 70 patients below 2 years from 4 different centers treated with ETV and assessed success.Methods Children < 2 years who received an ETV within 1994–2018 were included. Patients were classified according to age and etiology; < 3, 4–12, and 13–24 months, etiologically; aqueductal stenosis, post-hemorrhagic-hydrocephalus (PHH), tumor-related, fourth ventricle outflow obstruction, with Chiari-type II and following CSF infection. We investigated statistically the predictors for ETV success through computing Kaplan-Meier estimates using patient’s follow-up time and time to ETV failure.ResultsWe collected 70 patients. ETV success rate was 41.4%. The highest rate was in tumor-related hydrocephalus and fourth ventricle outlet obstruction (62.5%, 60%) and the lowest rate was in Chiari-type II and following infection (16.7%, 0%). The below 3 months age group showed relatively lower success rate (33.3%) in comparison to older groups which showed similar results (46.4%, 46.6%). Statistically, a previous VP shunt was a predictor for failure (p value < 0.05).Conclusion Factors suggesting a high possibility of failure were age < 3 months and etiology such as Chiari-type II or following infection. Altered CSF dynamics in patients with PHH and under-developed arachnoid villi may play a role in ETV failure. We do not recommend ETV as first line in children < 3 months of age or in case of Chiari II or following infection.
... Also to treat congenital AS resulting in secondary NCH, ETV has been proved to be a better option. Compared to posthemorrhagic patients or post-infective hydrocephalus group, ETV has been of better performance in aforementioned group (Chowdhury, Haque, et al., 2017). The results from research performed on hydrocephalus infants by Kulkarni et al. showed that initial treatment through ETV is more reasonable than using shunts. ...
Article
Full-text available
Introduction:Hydrocephalus is one of the most common diseases in children, and its treatment requires brain operation. However, the pathophysiology of the disease is very complicated and still unknown. Methods: Endoscopic Third Ventriculostomy (ETV) and Ventriculoperitoneal Shunt (VPS) implantation are among the common treatments of hydrocephalus. In this study, Cerebrospinal Fluid (CSF) hydrodynamic parameters and efficiency of the treatment methods were compared with numerical simulation and clinical follow-up of the treated patients. Results:Studies have shown that in patients under 19 years of age suffering from hydrocephalus related to a Posterior Fossa Brain Tumor (PFBT), the cumulative failure rate was 21% and 29% in ETV and VPS operation, respectively. At first, the ETV survival curve shows a sharp decrease and after two months it gets fixed while VPS curve makes a gradual decrease and reaches to a level lower than ETV curve after 5.7 months. Post-operative complications in ETV and VPS methods are 17% and 31%, respectively. In infants younger than 12 months with hydrocephalus due to congenital Aqueduct Stenosis (AS), and also in the elderly patients suffering from Normal Pressure Hydrocephalus (NPH), ETV is a better treatment option. Computer simulations show that the maximum CSF pressure is the most reliable hydrodynamic index for the evaluation of the treatment efficacy in these patients. After treatment by ETV and shunt methods, CSF pressure decreases about 9 and 5.3 times, respectively and 2.5 years after shunt implantation, this number returns to normal range. Conclusion: In infants with hydrocephalus, initial treatment by ETV was more reasonable than implanting the shunt. In adult with hydrocephalus, the initial failure in ETV occurred sooner compared to shunt therapy; however, ETV was more efficient.
Article
Full-text available
Background: Clinically erratic cerebrospinal fluid (CSF) outflow within brain ventricles was described as non-communicating and communicating hydrocephalous. Neurosurgical patients are commonly seen with increased intracranial pressure due to increased CSF accumulation. (1) Initially scientists followed ventriculoperitoneal shunt an inexpensive and available technique to treat hydrocephalous disorders. Due to least successful outcomes, Scientists used other alternative endoscopic techniques. These endoscopic techniques include aqueductal endoscopic stenting, aqueductoplasty and third ventriculostomy (2). Defining success rate of Endoscopic third ventriculostomy clinical and radiographic analysis are considered gold standard. Objectives: Our review aims to assess comparative role of patient age, patient selection, hydrocephalus etiology, surgical advancement and epigenetic treatment strategies following endoscopic third ventriculostomy focusing hydrocephalous. The main objectives of current study, to critically analyze available literature till to date and a step forward for the development of standard surgical protocols. Methodology: Clinical studies from Level I-IV published in English language focusing human subject only were only considered by retrieving NCBI/PubMed, Medline databases. Studies purely focusing third ventriculostomy in subject of patient age, hydrocephalus etiology and age associated complications were processed further. Objective based data inspection approach was followed. From each included study focusing third ventriculostomy detailed information demographic information was collected. Further data analysis was done by using SAS and multiple tools of Microsoft Excel Version 2010. Outcomes: From total 11 included studies specifically focusing hydrocephaly treatment via endoscopic third ventriculostomy, 757 patients with equal 1:1 male and female gender ratio and 125 cases of unknown gender were considered. Current study highlighting efficacy of Endoscopic third ventriculostomy at the rate of 77% effective treating obstructive hydrocephalus. On basis of etiological concerns about 36.32 % cases hydrocephalous cases were linked with encephalitis, underweight birth and nonspecific etiology. However, 24 % cases of hydrocephalus were led by group of tumors including, Ependymoma, Medulloblastoma, Meningioma, Cerebella pontine angle Tumors and Pineal gland carcinomas as well. 154 (20%) cases of obstructive hydrocephalus were associated with aqueduct stenosis, 16% cases reporting hemorrhage and only 23 cyst cases. Conclusion and future recommendations: Endoscopic third ventriculostomy (ETV) is a safe and effective (77%) treatment option for the treatment of obstructive hydrocephalus among all age groups. However, specifically highest efficacy was noted among patients of 15-30-year age group. Understanding disease etiology and patient selection criteria both are considered potential components Dipak Chaulagain et.al. Comparative role of hydrocephalus etiology and patient age following third ventriculostomy. following successful endoscopic third ventriculostomy. We highly recommend further research following a universal age criteria and reporting results in distinct age category to standardize ETV treating hydrocephaly efficiently.
Article
Full-text available
Fourth ventricle outflow obstruction (FVOO) is a rare cause of obstructive hydrocephalus. In this study, we described a case of idiopathic FVOO with ileal atresia and laryngomalacia which was managed with endoscopic third ventriculostomy (ETV) and re-endoscopy. We also described the techniques of fenestration of Liliequist membrane and partial removal of arachnoid membrane over dorsum sella (DS) to prevent closure of fenestration and recurrence of hydrocephalus. The patient was a 4-month-old infant presented with progressively increasing head size, feeding difficulty, respiratory distress, and tense fontanel. The infant had a history of laparotomy for ileal atresia. CT scan showed panventriculomegaly due to FVOO. ETV with fenestration of Liliequist membrane was done on emergency basis. After operation, the patient improved clinically and radiologically. Four weeks later, the patient returned with recurrent hydrocephalus. Endoscopic reoperation showed closure of fenestration in arachnoid membrane (Lilieqiest membrane). Endoscopic refenestration with partial excision of arachnoid on DS was done. The patient again recovered radiologically and clinically till last follow-up. In idiopathic FVOO, ETV with wide fenestration of Liliequist membrane, preferably with partial removal of arachnoid on DS, may be very useful in treating hydrocephalus (HCP) and preventing recurrent HCP even in infants.
Article
Full-text available
Hydrocephalus represents one of the most frequent pathologic entities requiring neurosurgical intervention. Even in present times the treatment of hydrocephalus is a highly debated subject. Neuroendoscopy is one of the technique posibility. The present study includes patients with different types of hydrocephalus classified according to imagistic criteria (MRI). Neuroendoscopic therapeutic options are presented for different types of hydrocephalus and the postoperative results of these procedures are revealed by imaging. In conclusion, we consider neuroendoscopy useful in each type of hydrocephalus.
Article
Full-text available
In this study, we were assessing the outcome of Endoscopic Third Ventriculostomy (ETV) in infants below six months of age in cases of congenital obstructive hydrocephalus. The study was done prospectively on eight cases of obstructive hydrocephalus in infants younger than six months of age to assess the success rate of ETV as a primary treatment for hydrocephalus in this age group; in cases of evident failure, a ventriculo-peritoneal (VP) shunt was applied. Despite eliminating the factors suggested as causes of ETV failure in infants below six months; the type, as with the communicating hydrocephalus, the thickness of the third ventricular floor, history of previous intracranial hemorrhage or central nervous system infection, still the success rate did not exceed 12.5%. The complication rate following ETV was low in comparison to the high frequency (20-80%) and seriousness of the possible postoperative complications following VP shunt with a significant decrease in the quality of patients' lives. Hence the decision-making as well as the parental counselling were in a trial to estimate the ETV success or the need to perform a shunt in the treatment of obstructive hydrocephalus.
Article
Full-text available
INCE its first description by Dandy, 4 third ventricu-lostomy has been performed to treat obstructive triventricular hydrocephalus without implanting ce-rebrospinal fluid (CSF) shunt devices. The percutaneous technique, performed using ventriculographic guidance as described by Guiot and colleagues, 7,8 made it possible for this procedure to be performed in large series of patients, allowing various indications for surgery to be identified. Patients with obstructive triventricular hydrocephalus due to primary aqueductal stenosis, toxoplasmosis, or tectomesencephalic, pineal, or posterior thalamic tumors were considered to be ideal candidates for third ventricu-lostomy, with a reported success rate of 75%. 19 The ad-vent of magnetic resonance (MR) imaging and neuroen-doscopy refined both the preoperative diagnosis and the surgical technique. Despite these improvements in diag-nosis and technique, third ventriculostomy failed to re-lieve the symptoms and signs of intracranial hypertension in a significant number of patients thought to be suitable for the procedure. To identify the reasons for failure of third ventricu-lostomy in the treatment of obstructive triventricular hy-drocephalus, we retrospectively analyzed a series of 213 patients treated in the Department of Pediatric Neuro-surgery at the Hôpital Necker–Enfants Malades between 1973 and 1997. Although in 1987 we modified our
Article
Full-text available
Endoscopic third ventriculostomy (ETV) is considered as a treatment of choice for obstructive hydrocephalus. It is indicated in hydrocephalus secondary to congenital aqueductal stenosis, posterior third ventricle tumor, cerebellar infarct, Dandy-Walker malformation, vein of Galen aneurism, syringomyelia with or without Chiari malformation type I, intraventricular hematoma, post infective, normal pressure hydrocephalus, myelomeningocele, multiloculated hydrocephalus, encephalocele, posterior fossa tumor and craniosynostosis. It is also indicated in block shunt or slit ventricle syndrome. Proper Pre-operative imaging for detailed assessment of the posterior communicating arteries distance from mid line, presence or absence of Liliequist membrane or other membranes, located in the prepontine cistern is useful. Measurement of lumbar elastance and resistance can predict patency of cranial subarachnoid space and complex hydrocephalus, which decides an ultimate outcome. Water jet dissection is an effective technique of ETV in thick floor. Ultrasonic contact probe can be useful in selected patients. Intraoperative ventriculo-stomography could help in confirming the adequacy of endoscopic procedure, thereby facilitating the need for shunt. Intraoperative observations of the patent aqueduct and prepontine cistern scarring are predictors of the risk of ETV failure. Such patients may be considered for shunt surgery. Magnetic resonance ventriculography and cine phase contrast magnetic resonance imaging are effective in assessing subarachnoid space and stoma patency after ETV. Proper case selection, post-operative care including monitoring of ICP and need for external ventricular drain, repeated lumbar puncture and CSF drainage, Ommaya reservoir in selected patients could help to increase success rate and reduce complications. Most of the complications develop in an early post–operative, but fatal complications can develop late which indicate an importance of long term follow up.
Article
Full-text available
This paper presents data from a retrospective study of endoscopic third ventriculostomy (ETV) in patients with shunt malfunction and proposes a simple and reasonable post-operative protocol that can detect ETV failure. We enrolled 19 consecutive hydrocephalus patients (11 male and 8 female) who were treated with ETV between April 2001 and July 2010 after failure of previously placed shunts. We evaluated for correlations between the success rate of ETV and the following parameters : age at the time of surgery, etiology of hydrocephalus, number of shunt revisions, interval between the initial diagnosis of hydrocephalus or the last shunt placement and ETV, and the indwelling time of external ventricular drainage. At the time of ETV after shunt failure, 14 of the 19 patients were in the pediatric age group and 5 were adults, with ages ranging from 14 months to 42 years (median age, 12 years). The patients had initially been diagnosed with hydrocephalus between the ages of 1 month 24 days and 32 years (median age, 6 years 3 months). The etiology of hydrocephalus was neoplasm in 7 patients; infection in 5; malformation, such as aqueductal stenosis or megacisterna magna in 3; trauma in 1; and unknown in 3. The overall success rate during the median follow-up duration of 1.4 years (9 days to 8.7 years) after secondary ETV was 68.4%. None of the possible contributing factors for successful ETV, including age (p=0.97) and the etiology of hydrocephalus (p=0.79), were statistically correlated with outcomes in our series. The use of ETV in patients with shunt malfunction resulted in shunt independence in 68.4% of cases. Age, etiology of hydrocephalus, and other contributing factors were not statistically correlated with ETV success. External ventricular drainage management during the immediate post-ETV period is a good means of detecting ETV failure.
Article
The authors have previously reported on the overall improved efficacy of endoscopic third ventriculostomy (ETV) combined with choroid plexus cauterization (CPC) for infants younger than 1 year of age. In the present study they specifically examined the long-term efficacy of ETV with or without CPC in 35 infants with congenital aqueduct stenosis treated at CURE Children's Hospital of Uganda during the years 2001-2006. Infants with congenital aqueductal stenosis were treated during 2 distinct treatment epochs: all underwent ETV alone, and subsequently all underwent ETV-CPC. Prospectively collected data in the clinical database were reviewed for all infants with an age < 1 year who had been treated for hydrocephalus due to congenital aqueductal stenosis. Study exclusion criteria included: 1) a history or findings on imaging or at the time of ventriculoscopy that suggested a possible infectious cause of the hydrocephalus, including scarred choroid plexus; 2) an open aqueduct or an aqueduct obstructed by a membrane or cyst rather than by stenosis; 3) severe malformations of the cerebral hemispheres including hydranencephaly, significant segments of undeveloped brain, or schizencephaly; 4) myelomeningocele, encephalocele, Dandy-Walker complex, or tumor; or 5) previous shunt insertion. The time to treatment failure was analyzed using the Kaplan-Meier method to construct survival curves. Log-rank (Mantel-Cox) and Gehan-Breslow-Wilcoxon tests were used to determine whether differences between the 2 treatment groups were significant. Thirty-five patients met the study criteria. Endoscopic third ventriculostomy alone was performed in 12 patients (mean age 4.7 months), and combined ETV-CPC was performed in 23 patients (mean age 3.5 months). For patients without treatment failure, the mean and median follow-ups were, respectively, 51.6 and 48.0 months in the ETV group and 31.2 and 26.4 months in the ETV-CPC group. Treatment was successful in 48.6% of the patients who underwent ETV alone, as accurately predicted by the Endoscopic Third Ventriculostomy Success Score (ETVSS), and in 81.9% of the patients who underwent ETV-CPC (p = 0.0119, log-rank test; p = 0.0041, Gehan-Breslow-Wilcoxon test; HR 6.42 [95% CI 1.51-27.36]). Combined ETV-CPC is significantly superior to ETV alone for infants younger than 1 year of age with congenital aqueductal stenosis. The fact that the outcome for ETV alone was accurately predicted by the ETVSS suggests that these results are applicable in developed countries.
Article
Background: The treatment of choice for several types of obstructive hydrocephalus is endoscopic third ventriculostomy (ETV). However, in certain cases ETV is not clearly superior to shunt placement, and a question of choice arises. Apart from the possibility of success in each case, knowledge of complication rates is of major importance as well. Material: Several series of ETVs have been published by various specialized centers. The reported overall complication rate is usually between 5% and 15%, and related permanent morbidity lower than 3%. The reported mortality of ETV is lower than 1%. Results: The most frequent intraoperative complications of ETV are hemorrhage (the most severe being due to basilar rupture) and injury of neural structures. In the immediate postoperative period, hematomas, infections, and cerebrospinal fluid leaks may present. Morbidity can be neurological and/or hormonal. Systemic complications are related more to the patient's general status and less to the procedure itself. Late sudden deterioration, leading as a rule to a patient's death, has been reported. Its incidence is not exactly known, but probably is lower than 0.1%. Nevertheless, the severity of this complication necessitates alertness and informing the patient. Conclusions: The complication rate of ETV is low, and rarely is a reason for choosing shunt placement instead. However, as a method it requires considerable experience, and several studies report a relation of experience not only with success rates but also with complication avoidance.
Article
Repeated cerebrospinal fluid (CSF) shunt failures in pediatric patients are common, and they are a significant cause of morbidity and, occasionally, of death. To date, the risk factors for repeated failure have not been established. By performing survival analysis for repeated events, the authors examined the effects of patient characteristics, shunt hardware, and surgical details in a large cohort of patients. During a 10-year period all pediatric patients with hydrocephalus requiring CSF diversion procedures were included in a prospective single-institution observational study. Patient characteristics were defined as age, gender, weight, head circumference, American Society of Anesthesiology class, and cause of hydrocephalus. Surgical details included whether the procedure was performed on an emergency or nonemergency basis, use of antibiotic agents, concurrent surgical procedures, and duration of the surgical procedure. Details on shunt hardware included: the type of shunt, the valve system, whether the shunt system included multiple or complex components, the type of distal catheter, the site of the shunt, and the side on which the shunt was placed. Repeated shunt failures were assessed using multivariable time-to-event analysis (by using the Cox regression model). Conditional models (as established by Prentice, et al.) were formulated for gap times (that is, times between successive shunt failures). There were 1183 shunt failures in 839 patients. Failure time from the first shunt procedure was an important predictor for the second and third episodes of failure, thus establishing an association between the times to failure within individual patients. An age younger than 40 weeks gestation at the time of the first shunt implantation carried a hazard ratio (HR) of 2.49 (95% confidence interval [CI] 1.68-3.68) for the first failure, which remained high for subsequent episodes of failure. An age from 40 weeks gestation to 1 year (at the time of the initial surgery) also proved to be an important predictor of first shunt malfunctions (HR 1.77, 95% CI 1.29-2.44). The cause of hydrocephalus was significantly associated with the risk of initial failure and, to a lesser extent, later failures. Concurrent other surgical procedures were associated with an increased risk of failure. The patient's age at the time of initial shunt placement and the time interval since previous surgical revision are important predictors of repeated shunt failures in the multivariable model. Even after adjusting for age at first shunt insertion as well as the cause of hydrocephalus, there is significant association between repeated failure times for individual patients.